NOTE 11 - STOCKHOLDERS' DEFICIENCY: Board of Directors fees (Details) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Directors' fees | $ 1,280,366 | $ 232,614 |
| Transaction 2 | ||
| Sale of Stock, Transaction Date | Sep. 26, 2019 | |
| Sale of Stock, Description of Transaction | the board of directors granted to each of its directors warrants to purchase 500,000 shares of common stock | |
| Sale of Stock, Price Per Share | $ 0.08 | |
| Transaction 3 | ||
| Sale of Stock, Transaction Date | Sep. 30, 2020 | |
| Sale of Stock, Description of Transaction | the board of directors granted to three of its directors warrants to purchase 500,000 shares of common stock | |
| Sale of Stock, Price Per Share | $ 0.10 | |
| X | ||||||||||
- Definition Represents the monetary amount of Directors' fees, during the indicated time period. No definition available.
|
| X | ||||||||||
- Definition Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Date the subsidiary or equity investee issued or sold stock, in CCYY-MM-DD format. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|